Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Long-term Debt / Equity

Acadia Pharmaceutica Long-term Debt / Equity Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Long-term Debt / Equity from 2010 to 2020.
  • Acadia Pharmaceutica Long-term Debt / Equity for the quarter ending June 06, 2020 was $1m a -8.23% decrease of 0m year over year
  • Acadia Pharmaceutica Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $1m a -8.23% decrease of 0m year over year
Other Ratios Metrics:
  • Acadia Pharmaceutica Total Debt / Capital for the quarter ending September 09, 2012 was $0m a -708.88% decrease of 0m year over year
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
  • Acadia Pharmaceutica Total Debt / Equity for the quarter ending September 09, 2012 was $0m a -710.06% decrease of 0m year over year
View Chart On Koyfin

Quarterly ACAD Long-term Debt / Equity Data

06/2020$1m
03/2020$1m
12/2019$1m
09/2019$1m
06/2019$2m
03/2019$2m
09/2010$-24m
06/2010$2m
03/2010$1m

Annual ACAD Long-term Debt / Equity Data

2019$1m